Follow
Iván Caballero
Iván Caballero
Novartis GNF
No verified email
Title
Cited by
Cited by
Year
Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas …
J Riley, S Brand, M Voice, I Caballero, D Calvo, KD Read
PLoS neglected tropical diseases 9 (9), e0004014, 2015
482015
In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis
A McBride, AM Hoy, MJ Bamford, DE Mossakowska, MP Ruediger, ...
Scientific Reports 7 (1), 10806, 2017
262017
Discovery and Biochemical Characterization of Plasmodium Thioredoxin Reductase Inhibitors from an Antimalarial Set
AJ Theobald, I Caballero, I Coma, G Colmenarejo, C Cid, FJ Gamo, ...
Biochemistry 51 (23), 4764-4771, 2012
212012
Identification of Selective Inhibitors of Plasmodium N-Myristoyltransferase by High-Throughput Screening
A Harupa, L De Las Heras, G Colmenarejo, S Lyons-Abbott, A Reers, ...
Journal of Medicinal Chemistry 63 (2), 591-600, 2019
192019
Discovery of enhancers of the secretion of leukemia inhibitory factor for the treatment of multiple sclerosis
L Vela, I Caballero, L Fang, Q Liu, F Ramón, E Díez, M de Los Frailes
Journal of biomolecular screening 21 (5), 437-445, 2016
122016
Development of a Novel High-Density [3H]Hypoxanthine Scintillation Proximity Assay To Assess Plasmodium falciparum Growth
C de Cózar, I Caballero, G Colmenarejo, LM Sanz, E Álvarez-Ruiz, ...
Antimicrobial Agents and Chemotherapy 60 (10), 5949-5956, 2016
102016
A high-throughput fluorescence-based assay for Plasmodium dihydroorotate dehydrogenase inhibitor screening
I Caballero, MJ Lafuente, FJ Gamo, C Cid
Analytical Biochemistry 506, 13-21, 2016
102016
The system can't perform the operation now. Try again later.
Articles 1–7